Ki Summary BindingDB logo
myBDB logout
Reaction Details
Report a problem with these data
TargetPromotilin
LigandBDBM85389
Substrate/Competitorn/a
Ki 3.1±n/a nM
CommentsPDSP_6064
Citation Tsukamoto, KKuboyama, NYamano, MNakazawa, TSuzuki, T In vitro pharmacological profile of SK-896, a new human motilin analogue. Pharmacology60:128-35 (2000) [PubMed]  Article
More Info.:Get all data from this article
 
Promotilin
Name:Promotilin
Synonyms:MLN | MOTI_RABIT | Motilin | Promotilin
Type:Enzyme Catalytic Domain
Mol. Mass.:14668.99
Organism:RABBIT
Description:Motilin 0 RABBIT::P27114
Residue:133
Sequence:
MVSRKAVAALLLVHVTAMLASQTEAFVPIFTYSELQRMQERERNRGHKKSLSVQQRSDAA
AAPRPAEPTLEEENGRMQLTAPVEIGMRMNSRQLEKYRAALEAAERAVHPDAPSRPCWPA
GGESGWSGEPSPT
Blast this sequence in BindingDB or PDB
  Blast E-value cutoff:
BDBM85389
n/a
NameBDBM85389
Synonyms:CAS_52906-92-0 | Motilin
TypeSmall organic molecule
Emp. Form.C120H188N34O35S
Mol. Mass.2699.049
SMILES[#6]-[#6]-[#6@H](-[#6])-[#6@H](-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6@@H](-[#6@@H](-[#6])-[#8])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccc(-[#8])cc1)-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#16]-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](-[#8])=O |r|
Structure
Search PDB for entries with ligand similarity:Similarity to this molecule at least: